Anson Funds Management LP - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 35 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Anson Funds Management LP ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2017$446,000
-68.0%
1,237,957
-48.5%
0.30%
-31.7%
Q2 2017$1,394,000
-0.4%
2,403,553
+112.2%
0.44%
+114.1%
Q1 2016$1,399,0001,132,7370.21%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q1 2016
NameSharesValueWeighting ↓
Anson Funds Management LP 1,132,737$1,399,0000.21%
Prospera Financial Services Inc 177,550$215,0000.05%
LBA Wealth Management, LLC 12,000$15,0000.01%
Cambridge Investment Research Advisors, Inc. 23,457$28,0000.00%
TIAA CREF INVESTMENT MANAGEMENT LLC 313,801$866,0000.00%
TEACHERS ADVISORS, LLC 148,551$410,0000.00%
Balentine LLC 55$00.00%
Capital Advisors, Ltd. LLC 177$00.00%
Vantage Investment Advisors, LLC 1,150$1,0000.00%
BLACKROCK ADVISORS LLC 5,453$7,0000.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders